Critical Reviews in Oncology/Hematology (open access),

Systematic review: Soluble immunological biomarkers in advanced non-small-cell lung cancer (NSCLC)

Publication date: Available online 5 May 2020Source: Critical Reviews in Oncology/HematologyAuthor(s): Finn Mildner, Sieghart Sopper, Arno Amann, Andreas Pircher, Georg Pall, Stefan Köck, Erin Naismith, Dominik Wolf, Gabriele Gamerith

Critical Reviews in Oncology/Hematology (open access)

00:18

Challenges and opportunities of cfDNA analysis implementation in clinical practice: Perspective of the International Society of Liquid Biopsy (ISLB)

Publication date: Available online 5 May 2020Source: Critical Reviews in Oncology/HematologyAuthor(s): Christian Rolfo, Andrés F. Cardona, Massimo Cristofanilli, Luis Paz-Ares, Juan Jose Diaz Mochon, Ignacio Duran, Luis E. Raez, Alessandro Russo, Jose A. Lorente, Umberto Malapelle, Ignacio Gil-Bazo, Eloisa Jantus-Lewintre, Patrick Pauwels, Tony Mok, María José Serrano, on behalf of the ISLB

Critical Reviews in Oncology/Hematology (open access)

00:18

Electrolyte disorders in advanced non-small cell lung cancer patients treated with immune check-point inhibitors: a systematic review and meta-analysis

Publication date: Available online 4 May 2020Source: Critical Reviews in Oncology/HematologyAuthor(s): Luca Cantini, Filippo Merloni, Silvia Rinaldi, Edoardo Lenci, Giulia Marcantognini, Tania Meletani, Ilaria Fiordoliva, Francesca Morgese, Mariangela Torniai, Giulia Ricci, Riccardo Giampieri, Rossana Berardi

Critical Reviews in Oncology/Hematology (open access)

00:18

The significance of stromal collagen organization in cancer tissue; an in-depth discussion of literature

Publication date: Available online 4 May 2020Source: Critical Reviews in Oncology/HematologyAuthor(s): Stéphanie M. Zunder, Hans Gelderblom, Rob A. Tollenaar, Wilma E. Mesker

Critical Reviews in Oncology/Hematology (open access)

00:18

Mark above section as read